Maria Rovithi

20142019
If you made any changes in Pure these will be visible here soon.

Research Output 2014 2019

2017

A phase 1/2 study of intermittent, high dose sunitinib in patients with advanced solid tumors.

Rovithi, M., Labots, M., Richard, Honeywell, Ten Tije, A. J., Ruijter, R., Skardhamar, M., Peters, G. J., Voortman, J. & Verheul, H. M. W., 20 May 2017, In : Journal of Clinical Oncology. 35

Research output: Contribution to journalMeeting AbstractAcademic

Development of bioluminescent chick chorioallantoic membrane (CAM) models for primary pancreatic cancer cells: A platform for drug testing

Rovithi, M., Avan, A., Funel, N., Leon, L. G., Gomez, V. E., Wurdinger, T., Griffioen, A. W., Verheul, H. M. W. & Giovannetti, E., 17 Mar 2017, In : Scientific Reports. 7, 44686.

Research output: Contribution to journalArticleAcademicpeer-review

Insight in taste alterations during treatment with protein kinase inhibitors

van der Werf, A., Rovithi, M., Langius, J. A. E., de van der Schueren, M. A. E. & Verheul, H. M. W., 1 Nov 2017, In : European Journal of Cancer. 86, p. 125-134 10 p.

Research output: Contribution to journalReview articleAcademicpeer-review

Pulsatile high-dose treatment with antiangiogenic tyrosine kinase inhibitors improves clinical antitumor activity

Rovithi, M. & Verheul, H. M. W., 1 Aug 2017, In : Angiogenesis. 20, 3, p. 287-289 3 p.

Research output: Contribution to journalLetterAcademicpeer-review

Response and toxicity prediction by MALDI-TOF-MS serum peptide profiling in patients with non-small cell lung cancer

Rovithi, M., Lind, J. S. W., Pham, T. V., Voortman, J., Knol, J. C., Verheul, H. M. W., Smit, E. F. & Jimenez, C. R., Jul 2016, In : Proteomics. Clinical applications. 10, 7, p. 743-749

Research output: Contribution to journalArticleAcademicpeer-review

Cross-resistance to clinically used tyrosine kinase inhibitors sunitinib, sorafenib and pazopanib

Gotink, K. J., Rovithi, M. N., de Haas, R. R., Honeywell, R. J., Dekker, H., Poel, D., Azijli, K., Peters, G. J., Broxterman, H. J. & Verheul, H. M. W., 2015, In : Cellular Oncology. 38, 2, p. 119-129

Research output: Contribution to journalArticleAcademicpeer-review

2014

High-dose, intermittent sunitinib as an alternative treatment strategy

Rovithi, M., de Haas, R. R., Honeywell, R. J., Voortman, J., Griffioen, A. W., Labots, M., Luik, A. M., Peters, G. J., Broxterman, H. J. & Verheul, H. M. W., 1 Oct 2014, In : Cancer Research. 74, 19

Research output: Contribution to journalMeeting AbstractAcademic